HAE
Clinical trials for HAE explained in plain language.
Never miss a new study
Get alerted when new HAE trials appear
Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Battle of the bleed: which hemorrhoid fix works best?
Disease control Recruiting nowThis study compares two standard procedures for treating bleeding internal hemorrhoids: hemorrhoidal artery embolization (HAE) and rubber band ligation (RBL). About 40 adults with chronic bleeding who haven't improved with simple treatments will be randomly assigned to one of the…
Matched conditions: HAE
Phase: NA • Sponsor: Jessica K. Stewart, MD • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New RNA drug aims to stop painful swelling attacks in rare genetic disease
Disease control Recruiting nowThis study tests an investigational drug called ADX-324 in 90 adults with hereditary angioedema (HAE) types 1 or 2. HAE causes sudden, painful swelling in the body. ADX-324 uses a technology called siRNA to lower a protein involved in triggering attacks. The goal is to see if the…
Matched conditions: HAE
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New artery-blocking procedure aims to stop hemorrhoid bleeding without surgery
Symptom relief Recruiting nowThis study tests a procedure called hemorrhoidal artery embolization (HAE) for people with internal hemorrhoids who have not had success with other treatments or cannot have surgery. HAE blocks the blood supply to the hemorrhoid tissue to reduce symptoms, especially bleeding. Abo…
Matched conditions: HAE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 04, 2026 16:18 UTC